So far no clinical or experimental evidences clearly explain how and which systemic sclerosis (SSc) patients will experience a functional and radiological progression of interstitial lung disease (ILD).

Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease

De Santis, Maria;
2012

Abstract

So far no clinical or experimental evidences clearly explain how and which systemic sclerosis (SSc) patients will experience a functional and radiological progression of interstitial lung disease (ILD).
Antibodies
Antibodies, Antinuclear
Antigens, CD19
Bronchoalveolar Lavage Fluid
CD4-CD8 Ratio
DNA Topoisomerases
Eosinophils
Female
Humans
Logistic Models
Lung
Lung Diseases, Interstitial
Male
Middle Aged
Risk Factors
Scleroderma, Systemic
Tomography, X-Ray Computed
Vital Capacity
Disease Progression
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11699/68435
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact